SuperworthKiniksa Pharmaceuticals International market cap KNSA
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $6B
- Highest close in our data
- $6.2B
- Oct 2026
Kiniksa Pharmaceuticals International is worth $6B at the close on Oct 23, 2026, at $76.73 a share.
That is up 108% over the last year and up 741% over five years.
Its highest close in our data was $6.2B in Oct 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $6B | $3B | $6.2B | +88% |
| 2025 | $3.2B | $1.3B | $3.3B | +120% |
| 2024 | $1.4B | $1.2B | $2B | +17% |
| 2023 | $1.2B | $747.1M | $1.3B | +18% |
| 2022 | $1B | $554.2M | $1.2B | +28% |
| 2021 | $810.8M | $712M | $1.6B | −33% |
| 2020 | $1.2B | $672.3M | $1.4B | +87% |
| 2019 | $642.1M | $287.5M | $1.3B | −48% |
| 2018 | $1.2B | $699.3M | $1.5B | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Kiniksa Pharmaceuticals International's size, closest first, today.
| Company | Market cap |
|---|---|
| KNSAKiniksa Pharmaceuticals International | $6B |
| LGNDLigand Pharmaceuticals | $6.1B |
| AMRXAmneal Pharmaceuticals | $6.5B |
| ALKSAlkermes plc. | $7.3B |
| TGTXTG Therapeutics | $8.3B |
| INDVIndivior Pharmaceuticals | $4.1B |
| PTGXProtagonist Therapeutics | $9B |
| ARQTArcutis Biotherapeutics | $3.9B |
| CORTCorcept Therapeutics | $9.3B |
| LQDALiquidia | $3.8B |
| OGNOrganon | $3.6B |
| Peer median | $6.3B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Kiniksa Pharmaceuticals International
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.